Clinical Trial Update: Gemcitabine and S-1 for Locally Advanced Unresectable or Metastatic Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of gemcitabine and S-1 in locally advanced unresectable or metastatic pancreatic cancer has been terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Andrew Ko | Conditions: Pancreatic Cancer | Phase 2 | Status: TERMINATED | Results posted: 2020-09-18